1. 2023
  2. MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

    Eleveld, T. F., Vernooij, L., Schild, L., Koopmans, B., Alles, L. K., Ebus, M. E., Dandis, R., van Tinteren, H., Caron, H. N., Koster, J., van Noesel, M. M., Tytgat, G. A. M., Eising, S., Versteeg, R., Dolman, M. E. M. & Molenaar, J. J., 2023, In: Frontiers in oncology. 13, 1130034.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. 2021
  4. High-throughput screening identifies idasanutlin as a resensitizing drug for venetoclax-resistant neuroblastoma cells

    Vernooij, L., Bate-Eya, L. T., Alles, L. K., Lee, J. Y., Koopmans, B., Jonus, H. C., Schubert, N. A., Schild, L., Lelieveld, D., Egan, D. A., Kerstjens, M., Stam, R. W., Koster, J., Goldsmith, K. C., Molenaar, J. J. & Dolman, M. M. E., 1 Jun 2021, In: Molecular cancer therapeutics. 20, 6, p. 1161-1172 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. 2019
  6. The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion

    van Golen, R. F., Reiniers, M. J., Marsman, G., Alles, L. K., van Rooyen, D. M., Petri, B., van der Mark, V. A., van Beek, A. A., Meijer, B., Maas, M. A., Zeerleder, S., Verheij, J., Farrell, G. C., Luken, B. M., Teoh, N. C., van Gulik, T. M., Murphy, M. P. & Heger, M., 1 Jun 2019, In: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 1865, 6, p. 1192-1200

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Time-Dependent Impact of Irreversible Electroporation on Pathology and Ablation Size in the Porcine Liver: A 24-Hour Experimental Study

    Vogel, J. A., van Veldhuisen, E., Alles, L. K., Busch, O. R., Dijk, F., van Gulik, T. M., Huijzer, G. M., Besselink, M. G., van Lienden, K. P. & Verheij, J., 1 Jan 2019, In: Technology in cancer research & treatment. 18, p. 1533033819876899

    Research output: Contribution to journalArticleAcademicpeer-review

  8. 2018
  9. FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis

    van Golen, R. F., Olthof, P. B., Lionarons, D. A., Reiniers, M. J., Alles, L. K., Uz, Z., de Haan, L., Ergin, B., de Waart, D. R., Maas, A., Verheij, J., Jansen, P. L., Damink, S. W. O., Schaap, F. G., van Gulik, T. M. & Heger, M., 2018, In: Scientific reports. 8, 1, p. 16529

    Research output: Contribution to journalArticleAcademicpeer-review

  10. RaS–MAPK pathway-driven tumor progression is associated with loss of CIC and other genomic aberrations in neuroblastoma

    Eleveld, T. F., Schild, L., Koster, J., Zwijnenburg, D. A., Alles, L. K., Ebus, M. E., Volckmann, R., Tijtgat, G. A., van Sluis, P., Versteeg, R. & Molenaar, J. J., 2018, In: Cancer research. 78, 21, p. 6297-6307

    Research output: Contribution to journalArticleAcademicpeer-review

  11. 2016
  12. Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy

    Weijer, R., Broekgaarden, M., Krekorian, M., Alles, L. K., van Wijk, A. C., Mackaaij, C., Verheij, J., van der Wal, A. C., van Gulik, T. M., Storm, G. & Heger, M., 2016, In: Oncotarget. 7, 3, p. 3341-3356

    Research output: Contribution to journalArticleAcademicpeer-review

  13. Inhibition of hypoxia-inducible factor 1 with acriflavine sensitizes hypoxic tumor cells to photodynamic therapy with zinc phthalocyanine-encapsulating cationic liposomes

    Broekgaarden, M., Weijer, R., Krekorian, M., van den IJssel, B., Kos, M., Alles, L. K., van Wijk, A. C., Bikadi, Z., Hazai, E., van Gulik, T. M. & Heger, M., 2016, In: NANO RESEARCH. 9, 6, p. 1639-1662

    Research output: Contribution to journalArticleAcademicpeer-review

  14. 2015
  15. IL-23 and IL-17 are not involved in hepatic ischemia reperfusion injury in mouse and man

    Olthof, P. B., van Golen, R. F., Reiniers, M. J., Kos, M., Alles, L. K., Maas, M. A. W., Verheij, J., van Gulik, T. M. & Heger, M., 2015, In: Journal of clinical and translational research. 1, 3, p. 180-189

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 Next

ID: 114874